OpGen
OPGN
$0.46
Share price
-6.14%
Change (1 day)
-38.67%
Change (1 year)
Categories
OpGen (OPGN) - P/B ratio
P/B ratio as of May 2024 : 2.17
According to OpGen
's latest financial reports the company has a price-to-book ratio of 2.17.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
OpGen - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.57 | 57.2% |
| 2022-12-31 | 0.9995 | -11.41% |
| 2021-12-31 | 1.13 | -47.89% |
| 2020-12-31 | 2.16 | 47.35% |
| 2019-12-31 | 1.47 | -56.75% |
| 2018-12-31 | 3.40 | -54.86% |
| 2017-12-31 | 7.52 | -4.57% |
| 2016-12-31 | 7.88 | 147.75% |
| 2015-12-31 | 3.18 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | 6.87 | 216.73% | 🇺🇸 USA |
 Enzo Biochem ENZ | 0.7889 | -63.64% | 🇺🇸 USA |